Zenicor Integrates Advanced AI for Arrhythmia Diagnostics

Zenicor Medical Systems AB is taking a decisive step toward the future of arrhythmia diagnostics by integrating advanced artificial intelligence into its ECG analysis platform. Through collaboration with AI company Medicalgorithmics, their DeepRhythmAI becomes part of the Zenicor Solution, strengthening Zenicor’s comprehensive solution for modern arrhythmia diagnostics. The solution will be available to Zenicor’s customers in all markets.

DeepRhythmAI is an advanced AI technology that identifies severe arrhythmias up to 14 times better than clinical staff. The platform enables faster, safer, and more accurate results.

By integrating DeepRhythmAI into the Zenicor Solution, healthcare providers can:
• Reduce the staff time spent on ECG interpretation
• Handle a higher volume of investigations efficiently
• Deliver faster, more precise analyses that benefits both clinicians and patients

“This collaboration takes our service to the next level – both for our customers and for our interpretation service Zenicor Direct. By combining Zenicor’s established solution, Zenicor Solution, with Medicalgorithmics’ groundbreaking AI, we are taking a major step forward for the future of arrhythmia diagnostics,” says Mats Palerius, CEO of Zenicor Medical Systems AB.

By embedding advanced AI into its platform, Zenicor strengthens its position as a leader in arrhythmia diagnostics and delivers a fully scalable solution that shortens wait times and optimises healthcare resources.

About Medicalgorithmics
The Medicalgorithmics Group, founded in 2005 and headquartered in Warsaw, Poland, is a global medtech company specializing in AI-driven and non-invasive solutions for heart diagnostics. The company’s mission is to improve patients’ heart health through intelligent technologies.

The company is listed on the Warsaw Stock Exchange (SWIG80) and operates in more than 20 countries. Its database of annotated heartbeats (billions of beats) enables advanced predictive analytics and helps improve diagnostic accuracy over traditional methods.
For more information, visit: https://www.medicalgorithmics.com/scientific-research/

About Zenicor
Founded in 2003, Zenicor Medical Systems is a pioneer in developing ECG-based systems and care pathways for arrhythmia diagnostics and stroke prevention. The company works closely with healthcare providers to develop and optimise their care pathway workflows for arrhythmia investigations, keeping the patient at the center while improving the efficiency of healthcare resources. Zenicor has been certified under the European Medical Device Regulation (MDR) since January 2023. For more information, visit: www.zenicor.se.

For more information, please contact:
Mats Palerius, CEO, Zenicor Medical Systems AB
+46 8 442 68 60
mats.palerius@zenicor.se

High-resolution images for download: http://zenicor.se/pressmaterial